- Home
- AARD vs UBFO Comparison
AARD vs UBFO Comparison
Compare AARD & UBFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- UBFO
- Stock Information
- Founded
- AARD 2017
- UBFO 1987
- Country
- AARD United States
- UBFO United States
- Employees
- AARD N/A
- UBFO N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- UBFO Major Banks
- Sector
- AARD Health Care
- UBFO Finance
- Exchange
- AARD Nasdaq
- UBFO Nasdaq
- Market Cap
- AARD 154.9M
- UBFO 162.0M
- IPO Year
- AARD 2025
- UBFO N/A
- Fundamental
- Price
- AARD $10.14
- UBFO $9.08
- Analyst Decision
- AARD Strong Buy
- UBFO
- Analyst Count
- AARD 4
- UBFO 0
- Target Price
- AARD $31.50
- UBFO N/A
- AVG Volume (30 Days)
- AARD 69.4K
- UBFO 26.4K
- Earning Date
- AARD 01-01-0001
- UBFO 04-17-2025
- Dividend Yield
- AARD N/A
- UBFO 5.21%
- EPS Growth
- AARD N/A
- UBFO N/A
- EPS
- AARD N/A
- UBFO 0.77
- Revenue
- AARD N/A
- UBFO $47,362,000.00
- Revenue This Year
- AARD N/A
- UBFO N/A
- Revenue Next Year
- AARD N/A
- UBFO N/A
- P/E Ratio
- AARD N/A
- UBFO $11.88
- Revenue Growth
- AARD N/A
- UBFO N/A
- 52 Week Low
- AARD $4.88
- UBFO $7.07
- 52 Week High
- AARD $19.58
- UBFO $10.49
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- UBFO 56.36
- Support Level
- AARD N/A
- UBFO $8.95
- Resistance Level
- AARD N/A
- UBFO $9.49
- Average True Range (ATR)
- AARD 0.00
- UBFO 0.24
- MACD
- AARD 0.00
- UBFO 0.05
- Stochastic Oscillator
- AARD 0.00
- UBFO 47.83
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.